Symptoms of non-small cell carcinoma

summary

Lung cancer is one of the most common malignant tumors in the world, and it has become the first cause of death in urban population in China. Non small cell lung cancer (NSCLC) includes squamous cell carcinoma (SCC), adenocarcinoma and large cell carcinoma. Compared with small cell carcinoma, the growth and division of NSCLC cells are slower, and the diffusion and metastasis are relatively late. Non small cell lung cancer accounts for about 80% of all lung cancer. About 75% of the patients are in advanced stage when they are found, and the 5-year survival rate is very low. Symptoms of non-small cell carcinoma? Let's talk about it

Symptoms of non-small cell carcinoma

Chest pain in the early stage of lung cancer is mild, mainly manifested as dull pain, dull pain, location is not certain, and the relationship with breathing is uncertain. If the pain continues to occur, then the cancer may involve the pleura.

There will be a small amount of bleeding when the tumor inflammation caused necrosis and capillary damage, often mixed with sputum, appearing intermittently or intermittently. Many patients with lung cancer are treated with sputum and blood. After blocking the bronchus, low fever tumors often have obstructive pulmonary lobes, with different degrees. Mild patients have only low fever, severe patients have high fever. After treatment, they can be temporarily improved, but they will relapse soon.

Cough lung cancer grows on the bronchopulmonary tissue, usually produces respiratory tract irritation symptoms and produces irritative cough. Non small cell lung cancer patients have fatigue, weight loss, loss of appetite, dyspnea, cough, hemoptysis and other local symptoms.

matters needing attention

Shape reduction surgery: it is suitable for a few patients, such as refractory pleural effusion and pericardial effusion. By resecting the pleural and pericardial planting nodules and removing part of the pericardium and pleura, the clinical symptoms caused by pericardial effusion and pleural effusion can be cured or relieved, and the life can be prolonged or the quality of life can be improved. Local and systemic chemotherapy should be performed simultaneously in the operation. Adjuvant chemotherapy and radiotherapy are often needed before or after surgery to improve the cure rate of surgery and the survival rate of patients. The 5-year survival rate was 30% - 44%; The mortality of surgical treatment was 1% - 2%.